Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

SZSE:002675.SZ

17.35 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011201020092008
Operating Activities:
Net Income 254.216352.816260.85517.473293.64388.793264.73200.315111.54107.866103.781104.936127.93950.62832.3615.11
Depreciation & Amortization 147.246125.093114.931102.7496.05180.47456.24543.94534.45226.17113.5469.5088.6547.2645.8555.339
Deferred Income Tax -24.75-3.337-5.9180.243-4.244-13.086-11.829-1.126-1.7380000000
Stock Based Compensation 1.576000000000000000
Change In Working Capital -308.003191.26311.164-82.39732.553-99.144-137.428-52.862-72.4-75.049-132.422-71.798-5.271-8.855-74.40615.412
Accounts Receivables 174.75-23.627129.89-20.062-122.754-197.717-114.556-183.558-50.614-15.6-69.565-47.3880000
Inventory 66.11-112.35610.509-94.722-280.56849.179-148.312-44.305-53.787-76.768-30.416-32.971-13.319-20.167-29.66-11.494
Accounts Payables -524.113330.58176.68432.144440.11962.479137.269176.12733.7390000000
Other Working Capital 3.669-3.337-5.9180.243-4.244-148.32310.884-8.557-18.6131.719-102.006-38.8288.04911.312-44.74726.906
Other Non Cash Items 47.71327.368256.63634.76274.131122.9425.3884.884-6.905-6.985-5.5071.8897.5047.989.595.707
Operating Cash Flow 276.945996.537943.581572.577696.376493.063208.935196.28166.68852.002-20.60344.535138.82657.017-26.60241.568
Investing Activities:
Investments In Property Plant And Equipment -511.945-389.612-530.158-262.187-250.076-121.054-143.925-131.17-82.042-66.499-173.131-71.964-17.725-16.055-23.57-5.304
Acquisitions Net -202.190.0330.287-99.111-103.70301.779-489.42142.91166.668-163.974000-18.2810.004
Purchases Of Investments -290.771-560.706-1,390.314-2,088.136-1,151.724-1,249.994-2,091.671-879.916-964.5-642.297-351.425000-3-0.398
Sales Maturities Of Investments 430.739495.8851,180.9381,905.1031,179.0111,348.211,104.613922.333991.343576.17272.73200023.6155.304
Other Investing Activites -29.7151.651013.611116.91595.6393.33928.5190.083-66.49916.375-71.9640.001-16.055-23.57-5.304
Investing Cash Flow -602.801-452.748-739.246-530.72-209.57772.802-1,127.644-549.655-12.205-132.456-399.422-71.964-17.724-16.055-44.805-5.698
Financing Activities:
Debt Repayment -105.169-906.42-521.183-1,630.372-1,062.478-710.845-758.242-325.42-334.177-313.733-208.083-141.605-269.136-308.231-198.919-215.095
Common Stock Issued 0000-3.700000000000
Common Stock Repurchased 00003.700000000000
Dividends Paid -123.689-120.332-200.554-200.554-38.506-132.821-84.385-50.461-34.855-25.302-28.556-35.132-22.976-7.78-15.627-6.776
Other Financing Activities 152.49798.532634.9761,836.494756.117847.8831,271.5421,216.159464.065363.686253.404696.859232.711329.887288.486188.12
Financing Cash Flow -0.676-359.126-188.682-141.487-552.8954.217428.915840.27895.03424.65116.765520.122-59.40113.87673.941-33.751
Other Information:
Effect Of Forex Changes On Cash 7.426.2646.749-3.318-5.5224.2596.0083.974-1.509-0.1660.0120.0110.692-0.1040.007-0
Net Change In Cash -319.113190.92622.402-102.948-71.617574.342-483.786490.879148.007-55.97-403.248492.70562.39354.7332.542.119
Cash At End Of Period 607.738926.851735.924713.522816.47888.087313.746797.532306.653158.646214.616617.864125.15962.7668.0325.492